Article
CRISPR based therapeutics: a new paradigm in cancer precision medicine
25 Mar 2022
Abstract excerpt
BACKGROUND: Clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein (Cas) systems are the latest addition to the plethora of gene-editing tools. These systems have been repurposed from their natural counterparts by means of both guide RNA and Cas nuclease engineering. These RNA-guided systems offer greater programmability and multiplexing capacity than previous generation gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
